康宁医院(02120.HK)拟1428万元收购长春康林医院51%股权
格隆汇9月9日丨康宁医院(02120.HK)宣布,公司全资子公司浙江康宁近日与长春康林医院股东杭州安肯及诺亚之舟投资签署股权转让协议,约定由浙江康宁以人民币1148万元收购股东杭州安肯持有的长春康林医院41%的股权及人民币280万元收购股东诺亚之舟投资持有的长春康林医院10%的股权。此次股权转让完成后,集团将持有长春康林医院51%的股权,长春康林医院成为集团的非全资附属公司。
截至公告日期,公司就长春康林医院股权变更事项正在办理必要的变更登记手续。
长春康林医院是一家位于中国吉林省长春市的营利性医疗机构,注册床位150张,现有物业最大可开放床位300张。
通过收购长春康林医院股权,公司将进一步扩大控股医疗机构网络。公司董事认为该收购与公司长远发展目标及战略相一致,同时符合公司及其股东之整体利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.